Endocrinological disorders in Duchenne Muscular Dystrophy: A case report
DOI:
https://doi.org/10.33448/rsd-v10i8.17773Keywords:
Muscular Dystrophy; Duchenne Muscular Dystrophy; Endocrinology.Abstract
Duchenne Muscular Dystrophy (DMD) is an inherited, autosomal recessive X-linked disease, affecting mainly males. There is progressive muscle impairment, starting with the proximal muscles of lower limbs, then reduction of upper limbs muscle strength and impairment of cardiac and respiratory muscles, with no curative therapy. Thus, this is a case report of a patient with Duchenne Muscular Dystrophy, emphasizing the possible endocrinological effects that can manifest in this pathology. The best medication for the management of Duchenne Muscular Dystrophy is corticosteroid, which improves muscle strength, extending gait time, preserving the function of upper limbs, preventing scoliosis, reducing cardiomyopathy progression and delaying invasive ventilation need. However, this medication offers a range of adverse effects to these patients, making endocrinological care necessary, with the following objectives: monitoring growth, pubertal development, diagnosing hormonal deficiencies, providing replacement therapy when necessary and preventing the occurrence of adrenal crisis.
References
Annexstad, E. J., Lund-Petersen, I., & Rasmussen, M. (2014). Duchenne muscular dystrophy. Tidsskrift for Den Norske Legeforening, 134(14), 1361–1364. https://doi.org/10.4045/tidsskr.13.0836
Araujo, A. P. Q. C., Nardes, F., Fortes, C. P. D. D., Pereira, J. A., Rebel, M. F., Dias, C. M., Barbosa, R. de C. G. A., Lopes, M. V. R., Langer, A. L., Neves, F. R., & Reis, E. F. (2018). Brazilian consensus on duchenne muscular dystrophy. Part 2: Rehabilitation and systemic care. Arquivos de Neuro-Psiquiatria, 76(7), 481–489. https://doi.org/10.1590/0004-282x20180062
Bianchi, M. L., Morandi, L., Andreucci, E., Vai, S., Frasunkiewicz, J., & Cottafava, R. (2011a). Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment. Osteoporosis International, 22(2), 529–539. https://doi.org/10.1007/s00198-010-1275-5
Bianchi, M. L., Biggar, D., Bushby, K., Rogol, A. D., Rutter, M. M., & Tseng, B. (2011b). Endocrine Aspects of Duchenne Muscular Dystrophy. Neuromuscular Disorders, 21(4), 298–303. https://doi.org/10.1016/j.nmd.2011.02.006
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., Street, N., Tomezsko, J., Wagner, K. R., Ward, L. M., & Weber, D. R. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology, 17(3), 251–267. https://doi.org/10.1016/S1474-4422(18)30024-3
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., Poysky, J., Shapiro, F., Tomezsko, J., & Constantin, C. (2010). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology, 9(1), 77–93. https://doi.org/10.1016/S1474-4422(09)70271-6
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987). Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell, 51(6), 919–928. https://doi.org/10.1016/0092-8674(87)90579-4
Kunkel, L. M. (1986). Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature, 322(6074), 73–77. https://doi.org/10.1038/322073a0
Leung, D. G., Germain-Lee, E. L., Denger, B. E., & Wagner, K. R. (2011). Report on the second endocrine aspects of duchenne muscular dystrophy conference December 1-2, 2010, Baltimore, Maryland, USA. Neuromuscular Disorders, 21(8), 594–601. https://doi.org/10.1016/j.nmd.2011.04.008
Moat, S. J., Bradley, D. M., Salmon, R., Clarke, A., & Hartley, L. (2013). Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK). European Journal of Human Genetics, 21(10), 1049–1053. https://doi.org/10.1038/ejhg.2012.301
Parente, R. C. M., Oliveira, M. A. P. De, & Celeste, R. K. (2012). Relatos e Série de Casos na Era da Medicina Baseada em Evidência. Brazilian Journal Os Videoendoscopic Surgery, 3, 67–70. http://www.sobracil.org.br/revista/jv030302/bjvs030302_063B.pdf
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. UFSM.
Salera, S., Menni, F., Moggio, M., Guez, S., Sciacco, M., & Esposito, S. (2017). Nutritional Challenges in Duchenne Muscular Dystrophy. Nutrients, 9(6), 594. https://doi.org/10.3390/nu9060594
Suthar, R., & Sankhyan, N. (2018). Duchenne Muscular Dystrophy: A Practice Update. The Indian Journal of Pediatrics, 85(4), 276–281. https://doi.org/10.1007/s12098-017-2397-y
Ward, L. M., Hadjiyannakis, S., McMillan, H. J., Noritz, G., & Weber, D. R. (2018). Bone Health and Osteoporosis Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics, 142(Supplement 2), S34–S42. https://doi.org/10.1542/peds.2018-0333E
Ward, L. M., & Weber, D. R. (2019). Growth, pubertal development, and skeletal health in boys with Duchenne Muscular Dystrophy. Current Opinion in Endocrinology & Diabetes and Obesity, 26(1), 39–48. https://doi.org/10.1097/MED.0000000000000456
Weber, D. R., Hadjiyannakis, S., McMillan, H. J., Noritz, G., & Ward, L. M. (2018a). Obesity and endocrine management of the patient with Duchenne muscular dystrophy. Pediatrics, 142(October 2018), S43–S52. https://doi.org/10.1542/peds.2018-0333F
Weber, D. R., Thomas, S., Erickson, S. W., Fox, D., Oleszek, J., Pandya, S., Venkatesh, Y., Westfield, C., & Ciafaloni, E. (2018b). Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet. Journal of Neuromuscular Diseases, 5(4), 497–507. https://doi.org/10.3233/JND-180317
Werneck, L. C., Lorenzoni, P. J., Ducci, R. D. P., Fustes, O. H., Kay, C. S. K., & Scola, R. H. (2019). Duchenne muscular dystrophy: An historical treatment review. Arquivos de Neuro-Psiquiatria, 77(8), 579–589. https://doi.org/10.1590/0004-282X20190088
Wood, C. L., Straub, V., Guglieri, M., Bushby, K., & Cheetham, T. (2016). Short stature and pubertal delay in Duchenne muscular dystrophy. Archives of Disease in Childhood, 101(1), 101–106. https://doi.org/10.1136/archdischild-2015-308654
Yin, R. K. (2015). O estudo de caso. Bookman
Yiu, E. M., & Kornberg, A. J. (2015). Duchenne muscular dystrophy. Journal of Paediatrics and Child Health, 51(8), 759–764. https://doi.org/10.1111/jpc.12868
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Gabriela Sacuno Bonilha; Isabel Cristina Ranzan; Marise Vilas Boas Pescador
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
